Express Scripts Holding (NASDAQ:ESRX) VP Glen D. Stettin sold 3,448 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of Express Scripts Holding (NASDAQ:ESRX) traded up $0.42 during mid-day trading on Thursday, reaching $76.08. 3,530,232 shares of the company’s stock were exchanged, compared to its average volume of 3,023,933. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61. The company has a market cap of $42,850.00, a P/E ratio of 12.64, a P/E/G ratio of 1.00 and a beta of 0.87. Express Scripts Holding has a twelve month low of $55.80 and a twelve month high of $76.32.

Express Scripts (NASDAQ:ESRX) last issued its earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.90. The business had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.74 EPS. analysts expect that Express Scripts Holding will post 7.03 earnings per share for the current fiscal year.

Express Scripts declared that its Board of Directors has approved a share buyback program on Monday, December 18th that authorizes the company to repurchase 45,000,000 outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Hedge funds have recently modified their holdings of the business. Burt Wealth Advisors boosted its stake in shares of Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after purchasing an additional 174 shares in the last quarter. Bank of Nova Scotia Trust Co. bought a new position in shares of Express Scripts during the third quarter valued at approximately $120,000. First Personal Financial Services boosted its stake in shares of Express Scripts by 199.1% during the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after purchasing an additional 1,400 shares in the last quarter. Monroe Bank & Trust MI boosted its stake in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after purchasing an additional 970 shares in the last quarter. Finally, Capstone Investment Advisors Netherlands B.V. boosted its stake in shares of Express Scripts by 49.3% during the second quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock valued at $179,000 after purchasing an additional 924 shares in the last quarter. Institutional investors and hedge funds own 88.28% of the company’s stock.

Several analysts have recently issued reports on ESRX shares. Royal Bank of Canada started coverage on shares of Express Scripts in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 target price on the stock. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. UBS Group lowered shares of Express Scripts from a “market perform” rating to an “underperform” rating in a research report on Monday, October 9th. Raymond James Financial reissued an “underperform” rating on shares of Express Scripts in a research report on Monday, October 9th. Finally, Zacks Investment Research raised shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research report on Monday, October 16th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. Express Scripts has a consensus rating of “Hold” and an average target price of $75.84.

COPYRIGHT VIOLATION WARNING: “Express Scripts Holding (ESRX) VP Glen D. Stettin Sells 3,448 Shares” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/04/express-scripts-holding-esrx-vp-glen-d-stettin-sells-3448-shares.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Insider Buying and Selling by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.